Genetics and AI for personalised supplements: what they can really optimise (and what they can’t)

Table of contents

1. Why do two people respond differently to the same supplement?
2. What DNA can reveal about nutrients, and where it stays silent
3. How consumer genetic reports are made, and why the same raw data gives different advice
4. What AI adds on top of genetics: predictions, nudges, and feedback
5. What clinical trials say about personalised nutrition so far
6. Why personalised studies can look impressive and still be misleading
7. A sensible "test–adjust–retest" routine for supplements
8. Safety boundaries: when "optimising" becomes risky
9. Privacy and accountability: who holds your data and who is responsible?

Why do two people respond differently to the same supplement?

A friend takes magnesium and sleeps better; you take it and feel nothing. The easy story is “your genes are different”, but most day-to-day variation comes from simpler things.

Response differences often come from baseline status and context. If you already have adequate intake, adding more rarely changes much. If you are low, a modest dose can feel like night and day.

In practice, this means: before blaming your DNA, ask what your body was missing, what else changed, and what you are actually measuring (symptoms, blood markers, performance, or just hope).

What DNA can reveal about nutrients, and where it stays silent

Genetic tests feel decisive because they give a clean answer, but nutrition is usually not a clean system. Most traits relevant to supplements are influenced by many small genetic differences plus lifestyle, illness, medication, and environment.

A single genetic change can be high-impact in rare cases, but most consumer reports rely on common variants called a single nucleotide polymorphism (SNP), which is one-letter DNA variation that usually shifts risk or response only slightly. Small shifts can still matter at scale, but they are easy to oversell for individuals.

Where genetics can be genuinely useful is mostly about identifying a narrow, testable question, not handing you a full supplement blueprint.

• Stronger use-cases (clearer signal, clearer action)
  • Identifying known high-risk patterns that change what you should avoid or check (for example, genes linked to iron overload risk, handled in clinical care rather than via supplement “tips”)
  • Flagging lactose intolerance likelihood to guide diet choices (a food example, but it shows what “high signal” looks like)
  • Informing medication response in pharmacogenetics, when a clinician is already making a prescribing decision
• Weaker use-cases (common in marketing, rarely decisive alone)
  • “You need more of X because you have variant Y” without any baseline lab data or dietary context
  • Long lists of micronutrient “needs” derived from many tiny associations
  • Claims that one variant predicts a complex outcome like “energy” or “recovery” in a reliable way

In practice, this means: treat genetics as a filter for what to verify, not as a verdict.

How consumer genetic reports are made, and why the same raw data gives different advice

People are often surprised that two companies can analyse the same DNA file and return different supplement guidance. That is not always fraud; it is often a chain of choices.

Most direct-to-consumer services use array testing that measures a subset of variants, then infers others using statistical methods. Two companies can also choose different studies to rely on, different thresholds for “meaningful”, and different ways of combining multiple small effects into one recommendation.

This is where the evidence logic matters. Nutrition–gene research is vulnerable to “true but small” effects that vanish when you change population, diet pattern, or outcome measure. It is also vulnerable to false positives when many variants and many nutrients are tested at once.

A few distortions show up repeatedly in this space:

• Selection effects: people who buy tests tend to be more health-motivated, which can make “personalised advice” look more powerful than it is.
• Residual confounding: diet, sleep, alcohol, and socioeconomic factors can imitate genetic effects in observational research.
• Multiple comparisons: the more things you test, the more “significant” results you will find by chance unless the study is designed to control this.

In practice, this means: the most important question is not “Is the gene real?” but “Is this gene-to-action link strong enough to change a decision for someone like me?”

What AI adds on top of genetics: predictions, nudges, and feedback

You already see the pattern: genetics is static, but life is not. AI becomes attractive because it can combine many moving inputs, update recommendations, and push you towards consistency.

The best use of AI in “personalised nutrition” is often not predicting a perfect supplement stack. It is reducing friction: reminders, meal planning, adherence, and turning messy tracking into a simple next step.

AI models typically learn from combinations of signals, not single causes. That makes them useful and also fragile. A model can look accurate inside one dataset and fail in real life because your habits, devices, and context differ from the training set.

• Where AI can help (when done well)
  • Combining diet logs, wearable data, symptoms, and lab markers into patterns you can act on
  • Flagging when your change is too many variables at once
  • Creating a feedback loop: plan → do → measure → adjust
• Where AI commonly fails
  • Overfitting to the original dataset, then underperforming on new people
  • Treating noisy inputs as truth (food tracking and sleep estimates are imperfect)
  • Blurring correlation with causation, then sounding more confident than the evidence

In practice, this means: the most useful AI systems are transparent about what they used, what they did not measure, and what would change the recommendation.

What clinical trials say about personalised nutrition so far

If you want the sober bottom line, it is this: personalised advice can shift behaviour a bit, but adding genetics has not consistently improved outcomes compared with using diet and phenotype information alone.

In the Food4Me European randomised trial, personalised nutrition advice delivered online led to modest improvements in dietary behaviour compared with standard advice, such as small shifts in diet quality and some targeted nutrients. Importantly, including genetic information on top of diet and phenotype did not clearly add extra benefit.

Systematic reviews and consensus work from dietetics organisations have reached a similar conclusion: the evidence base is still maturing, and trials that incorporate genetic results into nutrition care have not shown consistent, clinically meaningful advantages over non-genetic approaches.

AI-driven personalisation has its own evidence profile. Some work in metabolic monitoring shows that algorithm-based dietary guidance can change short-term physiological responses, such as post-meal glucose patterns, but that is not the same as proving long-term health benefit from supplement “optimisation”.

In practice, this means: the best-supported “personalisation” today often looks like targeted behaviour change plus measurement, not DNA-driven supplement design.

Why personalised studies can look impressive and still be misleading

It is easy to be impressed by a dashboard that updates daily. The harder question is whether the improvement is real, durable, and caused by the personalisation itself.

One common trap is confusing a short-term biomarker shift with a meaningful endpoint. Another is mistaking “more engagement” for “better biology”. Personalised programmes often work because they make people pay attention, not because the algorithm found a secret lever.

A useful technical concept here is regression to the mean, which means extreme measurements tend to move closer to average on retesting even without any intervention. If you test ten things, pick the worst three, and “optimise”, some improvement will happen automatically.

Common interpretation errors you can actively avoid:

• Treating a single baseline blood test as a permanent truth instead of a snapshot
• Changing five supplements at once, then attributing any change to the one you like most
• Assuming “genetic risk” equals “genetic destiny”, rather than a small tilt in probability
• Trusting a proprietary score without asking what outcome it was trained to predict
• Confusing “statistically significant” with “personally meaningful”

In practice, this means: demand simple before/after comparisons, stable measures, and a plan that isolates variables.

A sensible "test–adjust–retest" routine for supplements

Most people do not need a hyper-personalised stack. They need a clean method to stop guessing.

Start by defining one goal and one outcome you can track. “More energy” is too vague; “less mid-afternoon sleepiness rated 0–10” is trackable. Pair subjective tracking with objective data only when it adds clarity.

Then build personalisation in layers, from highest signal to lowest:

• Layer 1: correct obvious gaps (diet pattern, sleep, alcohol, training load)
• Layer 2: check baseline status for nutrients where testing is meaningful (and where symptoms are non-specific)
• Layer 3: trial one change at a time, at a dose that is sensible and time-limited
• Layer 4: use genetic information only to prioritise what to verify, not to justify megadoses
• Layer 5: use AI tools mainly for adherence and feedback, not for bold medical-sounding claims

A practical checklist that stays grounded:

• Choose one target at a time (one symptom or one lab marker)
• Keep everything else stable for 2–4 weeks where possible
• Document dose, timing, and co-factors (food, caffeine, training)
• Retest only what you can interpret (and at a sensible interval)
• Stop early if you get adverse effects or escalating complexity

In practice, this means: good personalisation looks boring on paper, and that is why it works.

Safety boundaries: when "optimising" becomes risky

“Optimising” becomes risky when it pushes you into high doses, stacked products, or interactions you do not notice. The danger is not that supplements are always harmful; it is that they are easy to combine without a coherent ceiling.

Risk rises with fat-soluble vitamins, minerals with narrow safety margins, and any situation where you have a medical condition or take regular medicines.

Situations where clinician input is especially prudent:

• Pregnancy, trying to conceive, or breastfeeding (because some nutrients have clear upper limits)
• Kidney disease, liver disease, thyroid disease, haemochromatosis, or malabsorption conditions
• Anticoagulant therapy, thyroid medication, epilepsy medication, and other narrow-therapeutic-index drugs
• High-dose “single nutrient” protocols, especially when stacked with fortified foods and multi-products

In practice, this means: the more “personalised” and high-dose a plan becomes, the more it should move from influencer logic to clinical logic.

Privacy and accountability: who holds your data and who is responsible?

A saliva kit feels like a harmless purchase, but your genetic data is not just yours. It can reveal information about relatives, ancestry, and disease risks you did not ask for.

Direct-to-consumer testing also separates three different responsibilities: analytical quality (does the lab measure what it claims?), clinical validity (does the variant predict what the report says?), and clinical utility (does acting on it help you). Many consumer products do not make those boundaries clear.

In the UK context, policy discussions have highlighted concerns about misleading results, external assessment of test performance, and clearer technical standards. On the clinical side, NHS-facing guidance emphasises that direct-to-consumer results should not be used as the sole basis for clinical action without confirmation through appropriate clinical pathways.

In practice, this means: before you hand over DNA or continuous health data, read what happens to your raw data, whether it is shared for research, and how you can delete or export it.